Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Inorg Biochem ; 226: 111631, 2022 01.
Article in English | MEDLINE | ID: mdl-34717251

ABSTRACT

The investigation of compounds capable of strongly and selectively interacting with DNA comprises a field of research in constant development. In this work, we demonstrate that a trinuclear coordination complex based on a dinuclear Fe(III)Zn(II) core designed for biomimicry of the hydrolytic enzyme kidney bean purple acid phosphatase, containing an additional pendant arm coordinating a Pd(II) ion, has the ability to interact with DNA and to promote its hydrolytic cleavage. These results were found through analysis of plasmid DNA interaction and cleavage by the trinuclear complex 1 and its derivatives 2 and 3, in addition to the analysis of alteration in the DNA structure in the presence of the complexes through circular dichroism and DNA footprinting techniques. The suggested covalent interaction of the palladium-containing complex with DNA was analysed using an electrophoretic mobility assay, circular dichroism, high resolution gel separation techniques and kinetic analysis. This is a new and promising metal complex targeted to nucleic acids and acting in two separate ways: strong DNA interaction and hydrolytic cleavage.


Subject(s)
Coordination Complexes/chemistry , DNA Cleavage , Deoxyribonucleases/chemistry , Metals/chemistry , Plasmids/chemistry
2.
ACS Med Chem Lett ; 11(3): 286-291, 2020 Mar 12.
Article in English | MEDLINE | ID: mdl-32184958

ABSTRACT

A novel metal complex was synthesized containing a purine derived ligand in order to increase its binding to DNA. We observed a huge increase in nuclease activity and, quite interestingly, an improvement on DNA sequence selectivity. A potential site of specific cleavage in the presence of a reductant in the reaction medium is suggested. We were able to synthesize a novel metal nuclease with improved activity on DNA, and with sequence specificity when exposed to a coreactant, this opens up new possibilities to create site specific and redox status modulated artificial nucleases.

3.
Molecules ; 24(11)2019 Jun 07.
Article in English | MEDLINE | ID: mdl-31181667

ABSTRACT

Two new complexes of Ru(II) with mixed ligands were prepared: [Ru(bpy)2smp](PF6) (1) and [Ru(phen)2smp](PF6) (2), in which smp = sulfamethoxypyridazine; bpy = 2,2'-bipyridine; phen = 1,10-phenanthroline. The complexes have been characterized by elemental and conductivity analyses; infrared, NMR, and electrospray ionization mass spectroscopies; and X-ray diffraction of single crystal. Structural analyses reveal a distorted octahedral geometry around Ru(II) that is bound to two bpy (in 1) or two phen (in 2) via their two heterocyclic nitrogens and to two nitrogen atoms from sulfamethoxypyridazine-one of the methoxypyridazine ring and the sulfonamidic nitrogen, which is deprotonated. Both complexes inhibit the growth of chronic myelogenous leukemia cells. The interaction of the complexes with bovine serum albumin and DNA is described. DNA footprinting using an oligonucleotide as substrate showed the complexes' preference for thymine base rich sites. It is worth notifying that the complexes interact with the Src homology SH3 domain of the Abl tyrosine kinase protein. Abl protein is involved in signal transduction and implicated in the development of chronic myelogenous leukemia. Nuclear magnetic resonance (NMR) studies of the interaction of complex 2 with the Abl-SH3 domain showed that the most affected residues were T79, G97, W99, and Y115.


Subject(s)
Antineoplastic Agents/chemical synthesis , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism , Organometallic Compounds/chemical synthesis , Ruthenium/chemistry , Sulfamethoxypyridazine/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Circular Dichroism , Humans , K562 Cells , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Molecular Structure , Organometallic Compounds/chemistry , Organometallic Compounds/pharmacology , Proto-Oncogene Proteins c-abl/chemistry , Proto-Oncogene Proteins c-abl/metabolism , Spectrometry, Mass, Electrospray Ionization , X-Ray Diffraction , src Homology Domains
4.
Dalton Trans ; 46(34): 11380-11394, 2017 Aug 29.
Article in English | MEDLINE | ID: mdl-28812750

ABSTRACT

The synthesis and characterization of three ligands and their respective heterobinuclear FeIIIZnII complexes were carried out, with the goal of mimicking the active site of purple acid phosphatases (PAPs). The ligand 2-hydroxy-3-(((2-hydroxy-5-methyl-3-(((2-(pyridin-2-yl)ethyl)(pyridin-2-ylmethyl)amino)methyl)benzyl)(pyridin-2ylmethyl)amino)methyl)-5-methylbenzaldehyde (H2L2) was synthesized and its complex (FeIIIZnIIL2) was used as a basis for comparison with similar complexes previously published in the literature. Subsequent modifications were conducted in the aldehyde group, where 1,2-ethanediamine and 1,4-diaminobutane were used as side chain derivatives. The compounds FeIIIZnIIL2 (1), FeIIIZnIIL2-et (2) and FeIIIZnIIL2-but (3) were characterized by spectroscopic methods (infrared and UV-Vis) and ESI-MS spectrometry. Theoretical calculations were performed to provide insights into the complex structures with FeIIIZnII structures. The hydrolytic activity was analyzed both with the model substrate 2,4-BDNPP and with DNA catalyzed by complexes 1, 2 and 3.


Subject(s)
2,4-Dinitrophenol/analogs & derivatives , Chelating Agents/chemistry , DNA/chemistry , Iron/chemistry , Organometallic Compounds/chemical synthesis , Organophosphates/chemistry , Zinc/chemistry , 2,4-Dinitrophenol/chemistry , Biomimetic Materials/chemical synthesis , Biomimetic Materials/chemistry , Chemistry Techniques, Synthetic , Hydrolases/metabolism , Hydrolysis , Ligands , Models, Molecular , Molecular Conformation , Organometallic Compounds/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...